Intravesical
Showing 1 - 25 of 525
BPH, Intravesical Botox, ThuLEP Trial (Thulium Laser Enucleation of the Prostate (ThuLEP), Intravesical Botox injection)
Not yet recruiting
- BPH
- +4 more
- Thulium Laser Enucleation of the Prostate (ThuLEP)
- Intravesical Botox injection
- (no location specified)
Jun 11, 2023
Upper Urinary Tract Urothelial Carcinoma, Bladder Cancer Trial in Vienna (Intravesical Solution)
Not yet recruiting
- Upper Urinary Tract Urothelial Carcinoma
- Bladder Cancer
- Intravesical Solution
-
Vienna, Austria
- +1 more
Mar 31, 2023
Bladder Cancer Trial in Goyang (intravesical mitomycin-C 40mg/20ml instillation)
Completed
- Bladder Cancer
- intravesical mitomycin-C 40mg/20ml instillation
-
Goyang, Korea, Republic ofNational Cancer Center
Jan 30, 2023
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)
Recruiting
- Non-muscle-invasive Bladder Cancer
-
Cairo, EgyptMohamed Fawzy Salman
Nov 19, 2022
High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)
Not yet recruiting
- High-risk Non-muscle Invasive Bladder Cancer
- (no location specified)
Oct 25, 2023
Bacillus Calmette Guerin With Use of Different Types of Urinary
Completed
- Non-muscle-invasive Bladder Cancer
-
Marathon, Attica, GreeceThemistoklis Bellos
Jan 10, 2023
Non-muscle-invasive Bladder Cancer Trial (Gemcitabine, Docetaxel, Bacillus Calmette Guerin)
Not yet recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine
- +2 more
- (no location specified)
Sep 9, 2022
Lower Urinary Tract Symptoms After Intravesical Therapy
Recruiting
- Chemotherapy Effect
- +3 more
- Validated questionnaires
-
Munich, Bavaria, GermanyNikolaos Pyrgidis
May 3, 2023
Non-muscle Invasive Bladder Cancer Trial (TARA-002)
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- TARA-002
- (no location specified)
Jul 14, 2023
Urinary Bladder Cancer Trial in Tucson (Gemcitabine)
Not yet recruiting
- Urinary Bladder Cancer
-
Tucson, ArizonaUniversity of Arizona Cancer Center
Dec 21, 2022
High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma, Perfusion; Complications, Intraoperative Complications Trial
Recruiting
- High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
- +2 more
- hyperthermic intravesical perfusion
-
Zhengzhou, Henan, ChinaBR-PRG
Sep 15, 2022
Urothelial Carcinoma Bladder, Sperm Count, Low, Testis; Fibrosis Trial (Bacillus Calmette Guerin)
Not yet recruiting
- Urothelial Carcinoma Bladder
- +2 more
- Bacillus Calmette Guerin
- (no location specified)
Jan 18, 2023
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Benign Prostatic Hyperplasia, Overactive Bladder Trial in Cleveland, Lyndhurst, Richmond Heights (Intravesical Botox injection)
Suspended
- Benign Prostatic Hyperplasia
- Overactive Bladder
- Intravesical Botox injection
-
Cleveland, Ohio
- +2 more
Dec 16, 2022
Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive
Recruiting
- Non Muscle Invasive Bladder Cancer
- N803 plus Bacillus Calmette-Guerin (BCG)
-
Honolulu, HawaiiIsland Urology
Aug 7, 2023
Spinal Cord Injuries, Neurogenic Bladder Trial in Washington (Lactobacillus RhamnosusGG, Saline bladder wash)
Recruiting
- Spinal Cord Injuries
- Neurogenic Bladder
- Lactobacillus RhamnosusGG
- Saline bladder wash
-
Washington, District of ColumbiaMedStar National Rehabilitation Hospital
Nov 10, 2022
Patient Satisfaction and Long-term Safety of Intravesical
Recruiting
- Urinary Tract Infections
- Recurrent Urinary Tract Infection
- Intravesical aminoglycoside instillations
-
Leiden, South Holland, NetherlandsLeiden University Medical Center
May 13, 2022
Non-muscle Invasive Bladder Cancer Trial in Aarhus (Urodynamic examination)
Recruiting
- Non-muscle Invasive Bladder Cancer
- Urodynamic examination
-
Aarhus, DenmarkAarhus University Hospital
Aug 5, 2022
Bladder Cancer, Epirubicin Adverse Reaction, Superficial Bladder Cancer Trial in Ankara (Intravesical Solution)
Recruiting
- Bladder Cancer
- +3 more
- Intravesical Solution
-
Ankara, Altindag, TurkeyAnkara Training and Research Hospital
Jul 4, 2022
Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)
Active, not recruiting
- Non-muscle-invasive Bladder Cancer
- Gemcitabine 1000 mg, Docetaxel 37.5g
-
Zagreb, CroatiaUniversity Hospital Centre Zagreb
Jan 20, 2023
Urothelial Carcinoma Trial in Goyang, Seoul (Intravesical 2000mg/52.6ml gemcitabine instillation, Normal saline)
Recruiting
- Urothelial Carcinoma
- Intravesical 2000mg/52.6ml gemcitabine instillation
- Normal saline
-
Goyang, Korea, Republic of
- +4 more
Apr 6, 2022
Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)
Not yet recruiting
- Urinary Bladder Neoplasms
- Receptors, Fibroblast Growth Factor
- Erdafitinib Intravesical Delivery System
-
Kanagawa, Japan
- +3 more
Jan 27, 2023
Voiding Disorders Trial in Mansoura (Mirabegron, Propevirine, Solifenacin)
Recruiting
- Voiding Disorders
- Mirabegron, Propevirine, Solifenacin
-
Mansoura, EgyptUrology and Nephrology Center, Mansoura University
Aug 3, 2022
Prostatic Adenoma Trial (Intravesical instillations of Ialuril® Prefill)
Not yet recruiting
- Prostatic Adenoma
- Intravesical instillations of Ialuril® Prefill
- (no location specified)
Jan 6, 2023